Revisión de la descompensación diabética aguda en adultos | 23 JUN 19

Cetoacidosis diabética y síndrome hiperosmolar hiperglucémico

La cetoacidosis diabética (CAD y el síndrome de hiperglucemia hiperosmolar (SHH) son emergencias que amenazan la vida y ocurren en pacientes con diabetes tipo 1 y tipo 2
34
101
Autor: Esra Karslioglu French, Amy C Donihi, Mary T Korytkowski BMJ 2019;365:l1114
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas
    1 Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2009;32:1335-43. 10.2337/dc09-9032 pmid:19564476.
    2 Joint British Diabetes Societies Inpatient Care Group. The management of diabetic ketoacidosis in adults. 2nd edition. 2013. http://www. diabetologists-abcd.org.uk/JBDS/JBDS_IP_DKA_Adults_Revised.pdf. 
    3 Pasquel FJ, Umpierrez GE. Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment. Diabetes Care 2014;37:3124-31. 10.2337/dc14-0984 pmid:25342831. 
    4 Scott AR. Joint British Diabetes Societies (JBDS) for Inpatient Care JBDS hyperosmolar hyperglycaemic guidelines group. Management of hyperosmolar hyperglycaemic state in adults with diabetes. Diabet Med 2015;32:714-24. 10.1111/dme.12757 pmid:25980647. 
    5 Handelsman Y, Henry RR, Bloomgarden ZT, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement On The Association Of SGLT-2 Inhibitors and Diabetic Ketoacidosis. Endocr Pract 2016;22:753-62. 10.4158/EP161292. PS pmid:27082665.
    6 American Diabetes Association. 15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019;42(Suppl 1):S173-81. 10.2337/dc19-S015 pmid:30559241.
    7 Umpierrez G, Korytkowski M. Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol 2016;12:222-32. 10.1038/ nrendo.2016.15 pmid:26893262.
    8 Wachtel TJ, Tetu-Mouradjian LM, Goldman DL, Ellis SE, O’Sullivan PS. Hyperosmolarity and acidosis in diabetes mellitus: a three-year experience in Rhode Island. J Gen Intern Med 1991;6:495-502. 10.1007/BF02598216 pmid:1765864.
    9 Munro JF, Campbell IW, McCuish AC, Duncan LJ. Euglycaemic diabetic ketoacidosis. Br Med J 1973;2:578-80. 10.1136/ bmj.2.5866.578 pmid:4197425. 
    10 Dhatariya KK, Umpierrez GE. Guidelines for management of diabetic ketoacidosis: time to revise?Lancet Diabetes Endocrinol 2017;5:321-3. 10.1016/S2213-8587(17)30093-1 pmid:28372975. 
    11 Troy PJ, Clark RP, Kakarala SG, Burns J, Silverman IE, Shore E. Cerebral edema during treatment of diabetic ketoacidosis in an adult with new onset diabetes. Neurocrit Care 2005;2:55-8. 10.1385/ NCC:2:1:055 pmid:16174971. 
    12 Benoit SR, Zhang Y, Geiss LS, Gregg EW, Albright A. Trends in Diabetic Ketoacidosis Hospitalizations and In-Hospital Mortality - United States, 2000-2014. MMWR Morb Mortal Wkly Rep 2018;67:362-5. 10.15585/ mmwr.mm6712a3 pmid:29596400. 
    13 Zhong VW, Juhaeri J, Mayer-Davis EJ. Trends in Hospital Admission for Diabetic Ketoacidosis in Adults With Type 1 and Type 2 Diabetes in England, 1998-2013: A Retrospective Cohort Study. Diabetes Care 2018;41:1870-7. 10.2337/dc17-1583 pmid:29386248. 
    14 Javor KA, Kotsanos JG, McDonald RC, Baron AD, Kesterson JG, Tierney WM. Diabetic ketoacidosis charges relative to medical charges of adult patients with type I diabetes. Diabetes Care 1997;20:349-54. 10.2337/ diacare.20.3.349 pmid:9051386. 
    15 Centers for Disease Control and Prevention. National Diabetes Statistics Report. 2017. https://www.cdc.gov/diabetes/data/statistics/statistics-report.html. 
    16 Vellanki P, Umpierrez GE. Diabetic ketoacidosis: A common debut of diabetes among african americans with type 2 diabetes. Endocr Pract 2017;23:971-8. 10.4158/EP161679.RA pmid:28534682. 
    17 Cefalu WT, Dawes DE, Gavlak G, et al. Insulin Access and Affordability Working Group: Conclusions and Recommendations. Diabetes Care 2018;41:1299-311. 10.2337/dci18-0019 pmid:29739814. 
    18 Dhatariya KK, Skedgel C, Fordham R. The cost of treating diabetic ketoacidosis in the UK: a national survey of hospital resource use. Diabet Med 2017;34:1361-6. 10.1111/dme.13427 pmid:28727175. 
    19 Delaney MF, Zisman A, Kettyle WM. Diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome. Endocrinol Metab Clin North Am 2000;29:683-705, V. 10.1016/S0889-8529(05)70159- 6 pmid:11149157. 
    20 Fadini GP, de Kreutzenberg SV, Rigato M, et al. Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center. Diabetes Res Clin Pract 2011;94:172-9. 10.1016/j.diabres.2011.06.018 pmid:21752485. 
    21 Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition. Diabetes Care 2015;38:1687-93. 10.2337/dc15-0843 pmid:26078479. 
    22 Meyer EJ, Gabb G, Jesudason D. SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A South Australian Clinical Case Series and Australian Spontaneous Adverse Event Notifications. Diabetes Care 2018;41:e47-9. 10.2337/dc17-1721 pmid:29440112. 
    23 Ueda P, Svanström H, Melbye M, et al. Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study. BMJ 2018;363:k4365. 10.1136/bmj.k4365 pmid:30429124. 
    24 Modi A, Agrawal A, Morgan F. Euglycemic Diabetic Ketoacidosis: A Review. Curr Diabetes Rev 2017;13:315-21. 10.2174/1573399812666160421121307 pmid:27097605.
    51 Wachtel TJ, Silliman RA, Lamberton P. Predisposing factors for the diabetic hyperosmolar state. Arch Intern Med 1988;148:747. 10.1001/ archinte.1988.00380030253040 pmid:3341875.
    52 Arieff AI, Carroll HJ. Cerebral edema and depression of sensorium in nonketotic hyperosmolar coma. Diabetes 1974;23:525-31. 10.2337/ diab.23.6.525 pmid:4834291.
    53 Hara JS, Rahbar AJ, Jeffres MN, Izuora KE. Impact of a hyperglycemic crises protocol. Endocr Pract 2013;19:953-62. 10.4158/EP13077. OR pmid:23807521.
    54 Bull SV, Douglas IS, Foster M, Albert RK. Mandatory protocol for treating adult patients with diabetic ketoacidosis decreases intensive care unit and hospital lengths of stay: results of a nonrandomized trial. Crit Care Med 2007;35:41-6. 10.1097/01.CCM.0000249825.18677. D2 pmid:17095944.
    55 Thuzar M, Malabu UH, Tisdell B, Sangla KS. Use of a standardised diabetic ketoacidosis management protocol improved clinical outcomes. Diabetes Res Clin Pract 2014;104:e8-11. 10.1016/j. diabres.2014.01.016 pmid:24507867.
    56 Ullal J, Aloi JA, Reyes-Umpierrez D, et al. Comparison of Computer- Guided Versus Standard Insulin Infusion Regimens in Patients With Diabetic Ketoacidosis. J Diabetes Sci Technol 2018;12:39-46. 10.1177/1932296817750899 pmid:29291648.
    57 Laliberte B, Yeung SYA, Gonzales JP. Impact of diabetic ketoacidosis management in the medical intensive care unit after order set implementation. Int J Pharm Pract 2017;25:238-43. 10.1111/ ijpp.12346 pmid:28338247.
    58 Martin C, McKinney ZJ, Hoody D, Fish L. Diabetic ketoacidosis critical care pathway implementation: Incorporation into emr significantly decreases length of stay. Endocr Pract 2016;22:673-8. 10.4158/EP151073. OR pmid:27176140.
    59 Devalia B. Adherance to protocol during the acute management of diabetic ketoacidosis: would specialist involvement lead to better outcomes?Int J Clin Pract 2010;64:1580-2. 10.1111/j.1742- 1241.2010.02348.x pmid:20846206.
    60 Tran TTT, Pease A, Wood AJ, et al. Review of Evidence for Adult Diabetic Ketoacidosis Management Protocols. Front Endocrinol (Lausanne) 2017;8:106. 10.3389/fendo.2017.00106 pmid:28659865.
    61 Patiño AM, Marsh RH, Nilles EJ, Baugh CW, Rouhani SA, Kayden S. Facing the Shortage of IV Fluids - A Hospital-Based Oral Rehydration Strategy. N Engl J Med 2018;378:1475-7. 10.1056/ NEJMp1801772 pmid:29561701.
    62 Misra S, Oliver NS. Utility of ketone measurement in the prevention, diagnosis and management of diabetic ketoacidosis. Diabet Med 2015;32:14-23. 10.1111/dme.12604 pmid:25307274.
    63 Dhatariya KK, Vellanki P. Treatment of Diabetic Ketoacidosis (DKA)/ Hyperglycemic Hyperosmolar State (HHS): Novel Advances in the Management of Hyperglycemic Crises (UK Versus USA). Curr Diab Rep 2017;17:33. 10.1007/s11892-017-0857-4 pmid:28364357.
    64 Ginde AA, Pelletier AJ, Camargo CA Jr. National study of U.S. emergency department visits with diabetic ketoacidosis, 1993-2003. Diabetes Care 2006;29:2117-9. 10.2337/dc06-0627 pmid:16936163.
    65 Sampson M, Jones C. Joint British Diabetes Societies (JBDS) for Inpatient Care. Joint British Diabetes Societies for Inpatient Care: clinical guidelines and improving inpatient diabetes care. Diabet Med 2018;35:988-91. 10.1111/dme.13672 pmid:30152584.
    66 Krentz AJ, Hale PJ, Singh BM, Nattrass M. The effect of glucose and insulin infusion on the fall of ketone bodies during treatment of diabetic ketoacidosis. Diabet Med 1989;6:31-6. 10.1111/j.1464-5491.1989. tb01135.x pmid:2522371.
    67 Karajgikar ND, Manroa P, Acharya R, et al. Addressing pitfalls in management of diabetic ketoacidosis (DKA) with a standardized protocol. Endocr Pract 2019. 10.4158/EP-2018-0398 pmid:30657360.
    68 Haas NL, Gianchandani RY, Gunnerson KJ, et al. The Two-Bag Method for Treatment of Diabetic Ketoacidosis in Adults. J Emerg Med 2018;54:593- 9. 10.1016/j.jemermed.2018.01.004 pmid:29628184.
    69 Munir I, Fargo R, Garrison R, et al. Comparison of a ‘two-bag system’ versus conventional treatment protocol (‘one-bag system’) in the management of diabetic ketoacidosis. BMJ Open Diabetes Res Care 2017;5:e000395. 10.1136/bmjdrc-2017-000395 pmid:28878933.
    70 Mazer-Amirshahi M, Fox ER. Saline Shortages - Many Causes, No Simple Solution. N Engl J Med 2018;378:1472-4. 10.1056/ NEJMp1800347 pmid:29561694.
    71 Kitabchi AE, Murphy MB, Spencer J, Matteri R, Karas J. Is a priming dose of insulin necessary in a low-dose insulin protocol for the treatment of diabetic ketoacidosis?Diabetes Care 2008;31:2081-5. 10.2337/dc08- 0509 pmid:18694978.
    72 Cardoso L, Vicente N, Rodrigues D, Gomes L, Carrilho F. Controversies in the management of hyperglycaemic emergencies in adults with diabetes. Metabolism 2017;68:43-54. 10.1016/j. metabol.2016.11.010 pmid:28183452.
    73 Loh TP, Saw S, Sethi SK. Bedside monitoring of blood ketone for management of diabetic ketoacidosis: proceed with care. Diabet Med 2012;29:827-8. 10.1111/j.1464- 5491.2011.03490.x pmid:21999575.
    74 Hsia E, Seggelke S, Gibbs J, et al. Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia. J Clin Endocrinol Metab 2012;97:3132-7. 10.1210/ jc.2012-1244 pmid:22685233. 
75 Doshi P, Potter AJ, De Los Santos D, Banuelos R, Darger BF, Chathampally Y. Prospective randomized trial of insulin glargine in acute management of diabetic ketoacidosis in the emergency department: a pilot study. Acad Emerg Med 2015;22:657-62. 10.1111/ acem.12673 pmid:26013711. 
76 Andrade-Castellanos CA, Colunga-Lozano LE, Delgado-Figueroa N, Gonzalez- Padilla DA. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis. Cochrane Database Syst Rev 2016;(1):CD011281.pm id:26798030. 
77 Ersöz HO, Ukinc K, Köse M, et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. Int J Clin Pract 2006;60:429-33. 10.1111/j.1368- 5031.2006.00786.x pmid:16620355. 
78 Umpierrez GE, Cuervo R, Karabell A, Latif K, Freire AX, Kitabchi AE. Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care 2004;27:1873-8. 10.2337/diacare.27.8.1873 pmid:15277410. 
79 Umpierrez GE, Latif K, Stoever J, et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med 2004;117:291-6. 10.1016/j. amjmed.2004.05.010 pmid:15336577. 
80 Karoli R, Fatima J, Salman T, Sandhu S, Shankar R. Managing diabetic ketoacidosis in non-intensive care unit setting: Role of insulin analogs. Indian J Pharmacol 2011;43:398-401. 10.4103/0253- 7613.83109 pmid:21844993. 
81 Chua HR, Schneider A, Bellomo R. Bicarbonate in diabetic ketoacidosis - a systematic review. Ann Intensive Care 2011;1:23. 10.1186/2110-5820-1- 23 pmid:21906367. 
82 Frontino G, Bonfanti R, Rigamonti A, et al. Management of hyperosmolar hyperglycaemic state in adults with diabetes. Diabet Med 2016;33:552. 10.1111/dme.12866 pmid:26206227. 
83 Magaji V, Nayak S, Donihi AC, et al. Comparison of insulin infusion protocols targeting 110-140 mg/dL in patients after cardiac surgery. Diabetes Technol Ther 2012;14:1013-7. 10.1089/dia.2012.0114 pmid:23046399. 
84 George S, Dale J, Stanisstreet D. Joint British Diabetes Societies (JBDS) for Inpatient Care JBDS Medical VRIII Writing Group. A guideline for the use of variable rate intravenous insulin infusion in medical inpatients. Diabet Med 2015;32:706-13. 10.1111/dme.12756 pmid:25980646. 
85 Mays JA, Jackson KL, Derby TA, et al. An Evaluation of Recurrent Diabetic Ketoacidosis, Fragmentation of Care, and Mortality Across Chicago, Illinois. Diabetes Care 2016;39:1671-6. 10.2337/dc16-0668 pmid:27422579. 
86 Donihi AC. Practical Recommendations for Transitioning Patients with Type 2 Diabetes from Hospital to Home. Curr Diab Rep 2017;17:52. 10.1007/ s11892-017-0876-1 pmid:28573408. 
87 Vellanki P, Umpierrez GE. Increasing Hospitalizations for DKA: A Need for Prevention Programs. Diabetes Care 2018;41:1839-41. 10.2337/dci18- 0004 pmid:30135197. 
88 Kimmel B, Sullivan MM, Rushakoff RJ. Survey on transition from inpatient to outpatient for patients on insulin: what really goes on at home?Endocr Pract 2010;16:785-91. 10.4158/EP10013.OR pmid:20350914. 
89 Krall JS, Donihi AC, Hatam M, Koshinsky J, Siminerio L. The Nurse Education and Transition (NEAT) model: educating the hospitalized patient with diabetes. Clin Diabetes Endocrinol 2016;2:1. 10.1186/s40842-016- 0020-1 pmid:28702237. 
90 Evans NR, Richardson LS, Dhatariya KK, Sampson MJ. Diabetes specialist nurse telemedicine: admissions avoidance, costs and casemix. Eur Diabetes Nurs 2012;9:17-2110.1002/edn.198. 
91 Berg EG. Sick-day rules: What to do when you are feeling under the weather. Diabetes Forecast 2013;66:32-3.pmid:24224354. 
92 Auchterlonie A, Okosieme OE. Preventing diabetic ketoacidosis: do patients adhere to sick-day rules?Clin Med (Lond) 2013;13:120. 10.7861/ clinmedicine.13-1-120 pmid:23472520. 
93 Scheen AJ. Pharmacokinetic Characteristics and Clinical Efficacy of an SGLT2 Inhibitor Plus DPP-4 Inhibitor Combination Therapy in Type 2 Diabetes. Clin Pharmacokinet 2017;56:703-18. 10.1007/s40262-016-0498- 9 pmid:28039605. 
94 Rosenbloom AL. Intracerebral crises during treatment of diabetic ketoacidosis. Diabetes Care 1990;13:22-33. 10.2337/ diacare.13.1.22 pmid:2105195. 
95 Kuppermann N, Ghetti S, Schunk JE, et al. PECARN DKA FLUID Study Group. Clinical Trial of Fluid Infusion Rates for Pediatric Diabetic Ketoacidosis. N Engl J Med 2018;378:2275-87. 10.1056/NEJMoa1716816 pmid:29897851. 
96 Wolfsdorf JI, Glaser N, Agus M, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes 2018;19(Suppl 27):155-77. 10.1111/pedi.12701 pmid:29900641. 
97 Mårtensson J, Bailey M, Venkatesh B, et al. Intensity of early correction of hyperglycaemia and outcome of critically ill patients with diabetic ketoacidosis. Crit Care Resusc 2017;19:266-73.pmid:28866977. 
98 Dhatariya KK. Diabetic ketoacidosis. BMJ 2007;334:1284-5. 10.1136/ bmj.39237.661111.80 pmid:17585123. 
99 Van Zyl DG, Rheeder P, Delport E. Fluid management in diabetic-acidosis- -Ringer’s lactate versus normal saline: a randomized controlled trial. QJM 2012;105:337-43. 10.1093/qjmed/hcr226 pmid:22109683. 
100 Mahler SA, Conrad SA, Wang H, Arnold TC. Resuscitation with balanced electrolyte solution prevents hyperchloremic metabolic acidosis in patients with diabetic ketoacidosis. Am J Emerg Med 2011;29:670-4. 10.1016/j.ajem.2010.02.004 pmid:20825879. 
    101 Issa M, Alqahtani F, Ziada KM, et al. Incidence and Outcomes of Non-ST Elevation Myocardial Infarction in Patients Hospitalized with Decompensated Diabetes. Am J Cardiol 2018;122:1297-302. 10.1016/j.amjcard.2018.07.004 pmid:30131108.
    102 Chen YL, Weng SF, Yang CY, Wang JJ, Tien KJ. Long-term risk of stroke in type 2 diabetes patients with diabetic ketoacidosis: A population-based, propensity score-matched, longitudinal follow-up study. Diabetes Metab 2017;43:223-8. 10.1016/j. diabet.2016.11.003 pmid:28129999.
    103 Azevedo LC, Choi H, Simmonds K, Davidow J, Bagshaw SM. Incidence and long-term outcomes of critically ill adult patients with moderate-to-severe diabetic ketoacidosis: retrospective matched cohort study. J Crit Care 2014;29:971-7. 10.1016/j. jcrc.2014.07.034 pmid:25220529.
 
 

Comentarios

Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí